Profile
AAPG VRTX REGN VRNA ARGX ALNY
Company Name ASCENTAGE PHARMA GROUP INTERNATIONAL Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $2.28B $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.57K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Dajun Yang Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
AAPG VRTX REGN VRNA ARGX ALNY
Quant Rating Score 1 4 4 1 4 3
Quant Rating Strong Sell Buy Buy Strong Sell Buy Neutral
Trading
AAPG VRTX REGN VRNA ARGX ALNY
Last Close $32.71 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $49.15 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $17.2 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -33.45 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 90.17 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
AAPG VRTX REGN VRNA ARGX ALNY
1 Month Return -7.7 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return -31.12 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 44.42 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 77.39 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 0 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 0 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AAPG VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) 31.31 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
AAPG VRTX REGN VRNA ARGX ALNY
Asset Growth 4.7 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth 397.05 % 1.16 % - 26.81 %
Revenue Growth 341.77 % 0.99 % - 22.97 %
Revenue 3 Year 640.43 % 20.64 % -15.89 % 147.1 %
Revenue 5 Year 1082.75 % 73.64 % - 775.72 %
Revenue 10 Year 2092.1 % 285.02 % - 2487.4 %
EBIT Growth 60.47 % 9.09 % -131.37 % 24.59 %
Net Income Growth 56.2 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share 89.08 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share 95.21 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share 35.57 % 680.22 % -35.51 % 55.09 %
Operating Income Growth 57.63 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) 84.66 % - -143.33 % -107.98 %
Operating 3 Year CFG 96.12 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG 95.77 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG 58.41 % -100 % 40.15 % 97.08 %
EPS Growth 89.79 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth 89.79 % 8.19 % -208.93 % 38.07 %
Book Value Per Share -9.31 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share -95.49 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share -94.81 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share 410 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth -7.08 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth 82.67 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
AAPG VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 90.87 % 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -38.05 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -249.24 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -62.03 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 101.38 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 102.02 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -286.93 % 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM 14.16 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM 4.98 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 0.3 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM 4.15 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM 44.8 % 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 12.82 % 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM 0.71 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM 0.69 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 486.54 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM 62.22 % 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 96.81 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM 14.16 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM 67.23 36.72 20 -995.27 127.92 195.85
Price To Operating Cash Flows Ratio TTM 239.07 32.86 16.23 -126.33 144.41 162.25
Price Cash Flow Ratio TTM 239.07 32.86 16.23 -126.33 144.41 162.25
Income Statement (TTM)
AAPG VRTX REGN VRNA ARGX ALNY
Revenue $0.98B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $0.95B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 97.03% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0.24B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.41B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -1.34 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
AAPG VRTX REGN VRNA ARGX ALNY
Long Term Debt $0.89B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $2.34B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $0.27B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0.03B $6.65B $15.75B $0.02B $1.93B $1.73B
Total Debt $1.67B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $2.62B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
AAPG VRTX REGN VRNA ARGX ALNY
Net Income $-0.4B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $0.01B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.11B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $-0.02B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AARD Aardvark Therapeutics, Inc. Common Stock 12.71
ABCL AbCellera Biologics Inc. 3.135
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.05
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.565
ABPWW 0.0133
ABSI Absci Corporation 2.62
ABUS Arbutus Biopharma Corporation 4.17
ABVC ABVC BioPharma, Inc. 1.74
ABVX Abivax SA American Depositary Shares 123.055
ACAD ACADIA Pharmaceuticals Inc. 22.47
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.81
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.29
ACIU AC Immune SA 3.03
ACLX Arcellx, Inc. 69.82
ETFs With Exposure to AAPG
Ticker ETF Name Weight Percentage Price
PGJ Invesco Golden Dragon China ETF 0.022 29.96
BOUT Innovator IBD Breakout Opportunities ETF 6.09 40.37
CANC Tema Oncology ETF 0.29 36.69
Unlock